Completed
There is broad recognition of the need to address the development and spread of antimicrobial resistance (AMR). A global, systematic analysis estimates that AMR infections lead to 1.27- 4.95 million deaths per year, and resistant bacterial infections are now a leading cause of neonatal mortality worldwide. However, a critical question remains on whether the impact of AMR is being fully understood and quantified throughout medical practice and everyday life, from cancer treatment to food production. Discussions at this workshop will cover current clinical and economic burdens of AMR, data availability and analytical methods, and potential strategies to incorporate these insights.
Featured publication
Assessing the Burden of and Potential Strategies to Address Antimicrobial Resistance: Proceedings of a Workshop—in Brief
Proceedings
·2024
Antimicrobial resistance (AMR) is linked to millions of deaths globally each year. As an evolving public health threat, there is a need to further develop methods to quantify AMR's burden within medical practice and other sectors like food production. The National Academies Forum on Microbial Threat...
View details